Grifols (GIFLF) Net Income towards Common Stockholders (QoQ) (2010 - 2020)

Grifols (GIFLF) Net Income towards Common Stockholders (QoQ) (2010 - 2020) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -55.46%
Mar 31, 2019 -75.72%
Jun 30, 2018 -20.67%
Mar 31, 2018 -70.06%
Jun 30, 2017 2.91%
Mar 31, 2017 64.74%
Dec 31, 2016 -66.80%
Sep 30, 2016 123.48%
Jun 30, 2016 -38.01%
Mar 31, 2016 128.68%
Dec 31, 2015 -8.18%
Sep 30, 2015 105,910.32%
Jun 30, 2015 -99.90%
Sep 30, 2013 -6.88%
Jun 30, 2013 -0.24%
Mar 31, 2013 -18.93%
Dec 31, 2012 85.62%
Sep 30, 2012 -5.80%
Jun 30, 2012 -4.28%
Mar 31, 2012 908.68%